Inhibition of complement reduces obliterative bronchiolitis

By Kallio E.   Lemstrom K.   Ryan U.   Hayry P.   Koskinen P.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 188-188

Elsevier

Access to resources Recommend Favorite

The role of the beta chemokines in experimental obliterative bronchiolitis

By Farivar A.S.   Krishnadasan B.   Naidu B.V.   Woolley S.M.   Mulligan M.S.  

Experimental and Molecular Pathology, Vol. 75, Iss. 3, 2003-12 ,pp. : 210-216

Elsevier

Access to resources Recommend Favorite

Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis

By Dosanjh A.K.   Wan B.   Throndset W.   Sherwood S.   Morris R.E.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1910-1911

Elsevier

Access to resources Recommend Favorite

Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis

By Naidu B.V.   Farivar A.S.   Woolley S.M.   Fraga C.   Salzman A.L.   Szabo C.   Groves J.T.   Mulligan M.S.  

Experimental and Molecular Pathology, Vol. 75, Iss. 1, 2003-08 ,pp. : 12-17

Elsevier

Access to resources Recommend Favorite

Cytomegalovirus Infection Accelerates Experimental Obliterative Bronchiolitis Via Platelet-Derived Growth Factor Upregulation

By Koskinen P.   Kallio E.   Tikkanen J.   Bruggeman C.   Hayry P.   Lemstrom K.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 798-798

Elsevier

Access to resources Recommend Favorite